Jesús
San Miguel Izquierdo
Consultor Investigador
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublicacións en colaboración con investigadores/as de University of Texas Southwestern Medical Center (1)
2021
-
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
Leukemia, Vol. 35, Núm. 6, pp. 1722-1731